Status:
NOT_YET_RECRUITING
European Registry of Acutely Decompensated Pulmonary Arterial Hypertension
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
European Respiratory Society
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
Brief Summary
Acute decompensation of pulmonary hypertension (PH) is associated with a very unfavorable short-term prognosis. However, the development of circulatory support techniques and the possible use of emerg...
Detailed Description
Precapillary pulmonary hypertension (PH) encompasses a group of diseases characterized by a progressive increase in pulmonary vascular resistance (PVR). The international clinical classification of PH...
Eligibility Criteria
Inclusion
- Patients with established diagnosis of pulmonary arterial hypertension (group 1) according to the 2022 ESC/ERS guidelines.
- Worsening of clinical signs of right heart failure in the month prior to hospital admission requiring the use of:
- intravenous diuretic therapy for ≥ 2 days
- or inotropes
- or vasopressors
Exclusion
- Patients with non-group 1 pulmonary hypertension
- Shock due to a cause other than right heart failure
- Person unable to provide written informed consent (person deprived of liberty by judicial or administrative decision)
- Person who is the subject of a legal protection measure (tutelage, guardianship, safeguard of justice)
- Person under psychiatric care
- Patient's objection to the use of their data
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06923917
Start Date
December 1 2025
End Date
December 1 2029
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique hopitaux de Paris
Le Kremlin-Bicêtre, France, 94270